Abstract
Objective
To evaluate the efficacy of clobazam in childhood refractory epilepsy and to characterize the adverse drug reaction profile in the Indian population.
Methods
A cohort of 88 children with ‘refractory’ epilepsy was started on clobazam as add-on therapy. Diagnosis was established and seizure type recorded. Therapeutic response was recorded as ‘complete’, ‘good’, and ‘no response’. Observed side effects were classified as ‘mild’, ‘moderate’ and ’severe’.
Results
Most children were on at least two antiepileptics. Seizures most identified were either partial (36.3%) or generalized tonic-clonic (15.9%). The dose ranged from 0.3–2 mg/kg/day (average 1+0.2 mg/kg/day). Clobazam was effective against all seizure types with complete seizure control seen in 60.2% patients. Tolerance was seen in 5 (5.6%) patients. Side effects were seen in 23 (26%) patients and were ‘mild’ in 20 (86.9%) of them. Clobazam was stopped in three patients who developed ataxia, which resolved on stopping the drug.
Conclusion
Clobazam was observed to be an effective broad-spectrum antiepileptic with ‘mild’ side effects in Indian children.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sugai K. Clobazam as a new anti epileptic drug and clorazepate dipotassium as an alternative antiepileptic drug in Japan. Epilepsia 2004; 45 Suppl 8: 20–25.
Keene DL, Whiting S, Humphreys P. Clobazam as an addon drug in the treatmet of refractory epilepsy of childhood. Can J Neurol Sci 1990; 17: 317–319.
Shimizu H, Kawasaki J, Yuasa S, Tarao Y, Kumagai S, Kanemoto K. Use of clobazam for the treatment of refractory complex partial seizures. Seizure 2003; 12: 282–286.
Bawden HN, Camfield CS, Camfield PR, et al. The cognitive and behavioural effects of clobazam and standard monotherapy are comparable. Canadian Study Group for Childhood Epilepsy. Epilepsy Res 1999; 33: 133–143.
Canadian Clobazam Cooperative Group. Clobazam in treatment of refractory epilepsy: The Canadian Experience. A retrospective study. Epilepsia 1991; 32: 407–416.
Theis JG, Koren G, Daneman R et al. Interactions of clobazam with conventional antiepileptics in children. J Child Neurol 1997; 12: 208–213.
Satishchandra P, Varadarajalu R, Rajaram P. Long term use of Clobazam in the management of intractable epilepsy. Neurol India 1998; 46: 284–287.
Mehndiratta MM, Krishnamurthy M, Rajesh KN, Singh G. Clobazam monotherapy in drug naive adult patients with epilepsy. Seizure 2003; 12: 226–228.
Kalra V, Seth R, Mishra D, Saha NC. Add on Clobazam in resistant childhood epilepsy-Adverse drug reaction study. Indian J Pediatr 2004; SS-1: 102.
Eypasch E, Lefering R, Kum CK, Troidl H. Probability of adverse events that have not yet occurred: a statistical reminder. BMJ 1995; 311: 619–620.
Shimizu H, Abe J, Futagi Y, et al. Antieileptic effects of clobazam in children. Brain Dev 1982; 4: 57–62.
Munn, Campfield P, Campfield C, Dooley J. Clobazam for refractory childhood seizure disorders-a valuable supplementary drug. Can J Neurol Sci 1988; 15: 406–408.
Canadian Study Group for Childhood Epilepsy. Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Epilepsia 1998; 39: 952–959.
Munn R, Farrell K. Open study of clobazam in refractory epilepsy. Pediatr Neurol 1993; 9: 465–469.
Montenegro MA, Cendes F, Noronha AL et al. Efficacy of clobazam as add on therapy in patients with refractory partial epilepsy. Epilepsia 2001; 42: 539–542.
Sheth RD, Ronen GM, Goulden KJ, Penney S, Bodensteiner JB. Clobazam for intractable pediatric epilepsy. J Child Neurol 1995; 10: 205–208.
Jan MM, Shaabat AO. Clobazam for the treatment of intractable childhood epilepsy. Saudi Med J 2000; 21: 622–624.
Barcs G, Halasz P. Effectiveness and tolerance of clobazam in temporal lobe epilepsy. Acta Neurol Scand 1996; 93: 88–93.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kalra, V., Seth, R., Mishra, D. et al. Clobazam in refractory childhood epilepsy. Indian J Pediatr 77, 263–266 (2010). https://doi.org/10.1007/s12098-010-0035-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-010-0035-z